Tag: Motley Fool

The Bubs Australia Ltd (ASX: BUB) share price has continued its decline and is trading lower again on Tuesday.

At the time of writing the infant formula and baby food company’s shares are down 0.5% to 78.5 cents.

This decline means the Bubs share price is now down 43% from its 52-week high.

Why is the Bubs share price under pressure?

The Bubs share price has come under pressure this morning following the release of an update on the retail component of the capital raising it announced with its full year results in August.

Bubs launched yet another dilutive capital raising last month to fund the acquisition of an ownership interest in a Beingmate manufacturing facility in Beihai China and to support its SAMR application for China-made Bubs Infant Formula products.

Given the difficulty of gaining approval to enter the lucrative China market from outside it, Bubs decided that it may have more success if it manufactures its products within it.

The company’s institutional placement was a smooth affair, with the company successfully raising $28.3 million at 80 cents per share.

However, its attempts to raise up to a further $11.7 million via a share purchase plan (SPP) haven’t gone to plan.

What did Bubs announce?

This morning the company advised that it would be extending the closing date of the SPP by two weeks from 23 September to 7 October.

It explained: “Due to delays being experienced with Australia Post deliveries during COVID-19 and feedback received from shareholders, the closing date for the SPP will be extended by a period of two weeks.”

This appears to be an indication that demand for the SPP has been subdued. Though, if this is the case, I wouldn’t imagine it is due to delays with the mail. Rather, I suspect it is because the Bubs share price has been trading below the SPP price of 80 cents for much of the last two weeks.

Management may be hoping that the Bubs share price gets a boost between now and 7 October to make the offer more attractive to retail shareholders. Because if Bubs fails to raise the funds, its growth plans will have to be scaled back accordingly.

More reading

• This week I’d buy Bubs (ASX:BUB) at today’s share price
• Where I’d invest $20,000 into ASX shares right now
• 3 ASX growth shares I’d buy right now
• Where I’d invest $20,000 into ASX shares right now
• 3 small cap ASX shares I’d buy with $3,000 right now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Bubs (ASX:BUB) share price lower on share purchase plan delay appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2RMi1mN

Last night’s US trading sessions saw multiple markets move lower simultaneously, presenting a red flag for the ASX this morning.

The volatile session saw multiple markets move lower overnight, triggering concerns that a wider selloff might be on our doorstep.

US markets

The S&P 500 Index (SP: .INX) lost as much as 2.8% in intraday trade, before recovering a little toward the end of the session. The overall loss after the late recovery sits at 1.29%, down around 40 points. This is a little less of a blow than the start of the session, however still low enough to cause concern with US investors.

Commodities

Commodity markets were also caught in the storm, particularly gold and silver.

The price of gold fell as much as 3.5% in intraday trade, however, like the US stock market, pulled back toward the end. The net loss at the end of the session was 2.05%. However, this is still a significant move for the precious metal, meaning that its price went from US$1,950 down to US$1,911 per ounce in a single session. At one point, the price reached as low as US$1,882 per ounce.

Silver fared far worse that its higher priced cousin, falling as much as 11.5% during trade. This is a significant blow to the silver price, which is now trading at only US$25 per ounce. Silver investors have enjoyed rapid growth in the price recently, as the precious metal reached highs of almost US$30 per ounce only a few short weeks ago.

Cryptocurrency

The price of bitcoin plummeted during last night’s activity. As the digital currency often moves in correlation with the gold and silver markets, this was not a surprise. However, it was still a blow to investors, with the price falling as much as 5.8% during the session. This leaves the price of bitcoin this morning at US$10,450, down from almost US $11,000 the previous day. 

More broadly, the entire cryptocurrency market saw wide selloffs, losing close to a staggering US$20 billion overnight. It’s a big blow for the market which only recently had begun to recover from the falls on 3 September. Early in the month, a huge selloff saw the market lose a massive US$60 billion over 2 days.

Australian market – ASX

Locally, we are expecting a drop in the market this morning, following the volatile session last night.

While the S&P/ASX 200 Index (ASX: XJO) closed at 5,822 points yesterday in Monday’s trade, futures indicate a lower open today. Contracts such as the Australian 200 AUD contract (OANDA: AU200AUD) fell as much as 60 points overnight. Currently, futures are pointing at the 5,780 point mark as the market opens today, meaning a down gap of around 40 points could present.

Foolish takeaway

It’s a rocky start to the week after a small loss yesterday on the ASX. Right now, it’s watch and wait for most Australian investors. Today will show whether we will see further declines or whether the market will see some short term stability in an attempt to find it’s feet. 

More reading

• Can the Harvey Norman (ASX:HVN) share price maintain its momentum?
• Up 79% this year, is the NextDC (ASX:NXT) share price the next Afterpay (ASX:APT)?
• Macquarie says ASX value shares will outperform growth stocks from here
• ASX 200 drops another 0.8%, Magellan (ASX:MFG) reveals a large investment
• 2 reliable blue chip ASX 200 shares to buy today

Motley Fool contributor glennleese has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Share, commodity and cryptocurrency markets fall overnight appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3chS9sv

The Commonwealth Bank of Australia (ASX: CBA) recently reviewed its forecast for house prices. Instead of the potential for up to 30% falls in residential house prices, the bank believes there will be a recovery in the second half of 2021. This means that ASX shares which have been sold down, are likely to see renewed interest over the next 6 months. I think this is pretty exciting and gives investors a chance to be in on the ground floor as prices rise.

Interestingly, CommBank has an empirical track record for accuracy.

ASX shares for communities

Stockland Corporation Ltd (ASX: SGP) is the glaring choice for best value ASX share in residential real estate. With a market cap of $8.6 billion, Stockland has a development pipeline of 76,000 lots of residential real estate. The company estimates this has an end market value of $21.4 billion.

Only 52% of these lots have been settled. However, the company has reported a level of pent up demand. Moreover, it has reported that since mid-May, residential real estate demand has recovered to above pre-COVID levels.

At the time of writing Stockland has a price to earnings ratio (P/E) of 13.14. It also has a trailing 12 month (TTM) dividend yield of 6.6%. The company is still down in year to date trading by 21.6%. Its share price has remained depressed due to the uncertainty in the housing market. I think this is a great entry point for this ASX share.

Residential houses and apartments

Another ASX share, Mirvac Group (ASX: MGR) has an an estimated value of $18.8 billion of residential real estate in progress, with a further $2 billion planned. According to the company’s H1 Analyst toolkit, it has only settled 37% of these houses. As with Stockland, the company posted disappointing FY20 results, including a drop in net profit after tax of 45%. However, this is to be expected considering most of the country was in lockdown from March to May, and into June.

Right now, Mirvac is selling at a P/E of 14.52, with a TTM dividend yield of 4.42%. This is another well-managed company that has been oversold on uncertainty, with a window of opportunity ahead of it. 

Foolish Takeaway

Both Stockland and Mirvac are great large cap ASX shares with a track record of delivering results. Stockland in particular is selling at a cheaper price, as compared to earnings, than it has done for the past 5 years. In addition, both pay solid dividends and have an existing pipeline of work ready to sell as conditions improve.

More reading

• CBA, Macquarie face new $167m dirty cash allegations
• ASX 200 Weekly Wrap: ASX 200 snaps 4 week losing streak… just
• Negative rates may be coming to a big four ASX bank near you
• ASX 200 down 0.8%: Fortescue (ASX:FMG) tumbles, Afterpay (ASX:APT) sinks lower
• ASX 200 up 0.7%: Afterpay (ASX:APT) higher, QBE Insurance (ASX:QBE) lower on UK update

Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 2 ASX shares to buy today for house price rise appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2RP3Ays

It only listed a week ago, but Access Innovation Holdings Ltd (ASX: AIM) has hit a hurdle.

The captioning tech and services provider, better known as AI-Media, sent a memo Monday to its customers that it’s struggling with the workload.

“While we continue to strive for 100% coverage, it has become quite challenging to cover all events, especially those with short turn-around times,” the memo read.

“If you’re planning to use our live enterprise services, please let us know with as much notice as possible and we will do our best to meet your needs.”

As a workaround, the memo suggested clients consider retrospectively captioning from a recording of the event or its transcription service as “high-quality alternatives”.

The new public company also stated it was training “a number of new captioners” and upgrading its technology.

“We really appreciate your patience during this time,” stated the memo.

“Please know that we understand the importance of your work and we are doing our best to meet the needs expressed.”

AI-Media did not respond to The Motley Fool’s request for comment in time.

AI-Media listed on the ASX last Tuesday with a market capitalisation of $177.4 million and an initial share price of $1.23. It was down 2.96% Monday, to sit at $1.31 after the close of trade.

What does AI-Media do?

Alex Jones, who was born deaf, identified the need for better captioning technology. He teamed with Tony Abrahams in 2003 to establish AI-Media.

Abrahams is still at the helm as chief executive officer. 

More than $50 million has been invested since 2009 into its main product – a cloud-based artificial intelligence platform.

The tech is combined with human captioners, transcribers and translators to provide the end result to customers.

“Using a combination of machine and human curation provides levels of accuracy that are greater than machines alone,” the prospectus read.

“This level of accuracy is a requirement to service AI-Media’s enterprise customers.”

AI-Media reported pro-forma revenue of $37.9 million for the 2020 financial year, while posting a $8.6 million net loss after tax. 

It forecasts a loss of $5.8 million for the 2021 financial year.

More reading

• Why ASX IPOs are almost always dangerous for new investors
• Access Innovation (ASX:AIM) share price rockets 23% higher on ASX debut
• ASX welcomes $180 million tech player on Tuesday

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post New ASX tech company warns customers it can’t cope appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2ROzQBy

Finding great ASX shares can be difficult, but that’s only half the challenge. The other half is holding onto great companies through good times and bad, to allow the magic of compounding increase your net worth. 

This has become harder recently as there are plenty of great technology and innovation companies that fly past like meteors. However, there are still many companies that will deliver consistent growth, and consistent dividends. The secret is to buy them at a great price and hold onto them as they grow. 

Resource ASX shares

The iron ore industry has been the great constant in my life. It started before I was born, grew with me, and will be raging long after I am gone. As a result, I started purchasing shares in Fortescue Metals Group Limited (ASX: FMG) at approximately $8 per share. Today, my average dollar cost is around $10 per share. This means I was able to secure a high dividend paying share at a low price. 

The company has a good future. It is in the finishing stages of developing two high grade iron ore mines, and selling into a market where demand is very strong. In addition, the company operates on solid operating margins. However, Fortescue is also expanding its metals portfolio. It recently announced a joint venture to explore part of the Paterson’s province in Western Australia for gold. Along with a number of exploration activities in South America for gold and copper. 

Fortescue is selling at a price to earnings ratio (P/E) of 7.73, which is just under half of BHP Group Ltd (ASX: BHP). At this price it has a trailing 12-month (TTM) dividend yield of 10.86%.

Finding solid resource investments like this in the early stages can be difficult. Right now, I think that two companies with potential for solid growth are Base Resources Limited (ASX: BSE), and maybe Ecograf Ltd (ASX: EGR).

Real estate

After the coronavirus market rout in March, I started to buy shares in Centuria Office REIT (ASX: COF). The company is a real estate investment trust (REIT), thus there are laws governing transparency and how much it has to pay out in distributions. I like this REIT for a few reasons.

First, it is the country’s largest pure play office REIT. This means it is not diversified and directs all of its resources into commercial buildings. This sector has been quite resilient to COVID-19 in general, but more so for Centuria Office REIT. That is because many of the company’s tenants are government departments. Second, it has a long weighted average lease expiry, currently 4.7 years. 

Right now the company is paying a TTM dividend yield of 8.48% and has a P/E of 12.6. I have no intention of selling this as it is a high paying dividend ASX share which forms part of my passive revenue streams. 

Other companies that are similar right now include DEXUS Property Group (ASX: DXS), and Abacus Property Group (ASX: ABP).

More reading

• 4 dividend kings to buy now and hold forever
• Why I like Saracen (ASX:SAR) and these ASX mining shares today
• Iron ore slumps: Does this make the BHP (ASX:BHP) share price and other miners a buy? 
• Buy Fortescue and this ASX dividend share for a source of income
• ASX 200 drops 1.2%, Mineral Resources (ASX:MIN) fell 9%

Motley Fool contributor Daryl Mather owns shares of Centuria Office REIT and Fortescue Metals Group Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 2 ASX shares I’m never selling appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3hRP8A7

Like the rest of the market, the healthcare sector has been out of form over the last few weeks.

This has led to the S&P/ASX 200 Health Care index losing 8% of its value in just a touch over a month.

Given the quality on offer at this side of the market, I believe this has created a buying opportunity for long-term focused investors.

With that in mind, here are two quality ASX healthcare shares I would buy today:

CSL Limited (ASX: CSL)

The CSL share price has been uncharacteristically out of form over the last few months and is down over 17% from its 52-week high. This has been driven by concerns over difficult plasma collection conditions. These collections are part of the manufacturing process for its lucrative immunoglobulins therapies. The pandemic is putting pressure on collection volumes, leading to lower donations and higher costs. This is likely to weigh on the margins of this key product range.

However, I’m confident that the company will overcome this and still deliver solid earnings growth in FY 2021. Especially given the expected increase in demand for influenza vaccines in the Northern Hemisphere winter. Looking further ahead, I believe its research and development pipeline holds a number of very lucrative therapies which could be key drivers of growth in the future. Overall, I feel the recent weakness in the CSL share price is a fantastic buying opportunity for investors.

ResMed Inc. (ASX: RMD)

Another high quality ASX healthcare share to buy is ResMed. This sleep treatment-focused medical device company’s shares are down 21% from their 52-week high. I believe this is a buying opportunity for investors looking for long term options in the sector.

This is because, thanks to its world class products, intuitive software solutions, and rapidly growing ecosystem, I’m confident the company can grow its earnings at a solid rate throughout the 2020s and beyond. Especially considering its massive and growing addressable market. Management estimates that there are 936 million sleep apnoea sufferers globally, with the vast majority of these undiagnosed. Given the growing education of the condition, I expect more and more diagnoses to be made over the coming years. This should underpin strong demand for ResMed’s products and software solutions.

More reading

• 2 reliable blue chip ASX 200 shares to buy today
• ASX 200 Weekly Wrap: ASX 200 snaps 4 week losing streak… just
• 5 stellar ASX growth shares that could smash the market in the 2020s
• Where I would invest $100,000 into ASX shares
• 3 high quality ASX growth shares to invest $3,000 into right now

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why now could be a good time to buy CSL (ASX:CSL) and ResMed (ASX:RMD) shares appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/32O0rVR

Commonwealth Bank of Australia (ASX: CBA) and Macquarie Group Ltd (ASX: MQG) have been accused of letting $167 million of criminal money move around the globe.

International Consortium of Investigative Journalism (ICIJ) on Monday revealed a massive leak of confidential reports that showed overseas banks warning Australian counterparts about suspicious transactions.

Despite this, more than $174 million of allegedly dirty money came in and out of Australian financial institutions. Macquarie alone was responsible for $123 million.

CBA allegedly had $44 million come in or out of it that raised alarm bells with foreign banks.

AUSTRAC is the Australian authority that oversees suspicious financial transactions. A couple of years ago, it raised a series of cases against local banks, including CBA and Westpac Banking Corp (ASX: WBC), about not reporting transactions that could be money laundering.

Commonwealth Bank ended up copping a $700 million penalty as a result.

Macquarie has previously avoided trouble with AUSTRAC, indicating the dodgy transactions shown in the ICIJ leak are a new discovery.

The Motley Fool has contacted Macquarie for comment.

A CBA spokesperson told The Motley Fool that the bank can’t comment on specific customers or transactions.

“We recognise that we play a critical role in protecting our customers and the community from the risks associated with money laundering and terrorism financing,” said the spokesperson.

“We work closely with law enforcement bodies that are involved in regulating and enforcing laws relating to financial crime.”

More reading

• Macquarie says ASX value shares will outperform growth stocks from here
• ASX 200 Weekly Wrap: ASX 200 snaps 4 week losing streak… just
• Negative rates may be coming to a big four ASX bank near you
• Macquarie (ASX:MQG) to earn $1 billion from a company you never heard of
• Why the lagging Worley (ASX:WOR) share price could be at COVID turning point

Motley Fool contributor Tony Yoo owns shares of Macquarie Group Limited. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post CBA, Macquarie face new $167m dirty cash allegations appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3cjOdHs

Costa Group Holdings Ltd (ASX: CGC) has slipped under my radar this year. The Costa Group share price surged higher in 2018 before its market value tumbled in troubled times last year.

However, 2020 has been a funny year so far. The coronavirus pandemic has smashed many ASX shares and the March bear market saw valuations fall off a cliff. That wasn’t the case for the Costa Group share price which has managed to steadily climb 33.5% higher this year.

That includes a 2.8% surge in yesterday’s trade, which has me wondering if the Aussie food producer’s shares are a cheap buy today.

What does Costa Group do?

Costa Group is Australia’s largest horticultural company and a major Aussie food producer. The company specialises in fresh fruit and vegetables with major products including avocados, berries, citrus, mushrooms and table grapes.

The Costa Group share price has been performing well this year as the company’s market capitalisation has swelled to $1.34 billion with a 1.3% dividend yield.

Why the company’s shares are surging

It’s worth digging into why the Costa Group share price has been climbing in 2020. The major catalyst has been the strong demand factors, and more recently, a strong FY20 result.

Supermarket sales have surged in 2020 as panic buying and the shutdown of the hospitality sector increased demand for groceries. That has been good news for major food producers like Costa Group and Bega Cheese Ltd (ASX: BGA).

Strong demand translated into strong FY20 earnings as Costa Group posted a 6.8% increase in revenue to $612.4 million.

Net profit after tax and before self-generating and regenerating assets, leasing and material items (NPAT-SL) jumped 12% to $45.8 million.

That was enough to send the group’s shares surging to a new 52-week high of $3.74 per share in late August.

Is the Costa Group share price a cheap buy?

I think the FY21 outlook is still strong for Costa Group. Demand remains strong and tough restrictions are likely to boost supermarket sales in the early part of the year.

The Costa Group share price has retreated from its 52-week high to $3.5 per share and could be worth a look given the strong fundamentals.

More reading

• 5 things to watch on the ASX 200 on Wednesday
• Is the Tassal (ASX:TGR) share price a strong buy?
• 3 simple ways to save more cash to buy ASX shares today!
• 5 things to watch on the ASX 200 next week
• Why ASX dividend shares are still king in 2020

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Is the Costa Group (ASX:CGC) share price a cheap buy? appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3iMzbMZ

If you have $3,000 to invest in ASX growth shares, then I think the ones listed below would be top options after recent market weakness.

Here’s why I would invest $1,000 across each of these growth shares:

Kogan.com Ltd (ASX: KGN)

The first ASX growth to consider investing $1,000 into is Kogan. I believe this ecommerce company’s shares could be market beaters over the 2020s thanks to the continued rise in online shopping and the growing popularity of its Kogan-branded products and Marketplace. In addition to this, Kogan’s expansion into potentially lucrative verticals such as energy and mobile should be supportive of its growth. As should its $120 million capital raising. The company plans to use these funds to make value accretive acquisitions in the near future.

NEXTDC Ltd (ASX: NXT)

Another top ASX growth share for investors to put $1,000 into is NEXTDC. It is a growing data centre operator which owns a collection of world class centres in key locations across Australia. In FY 2020 NEXTDC delivered a 23% increase in EBITDA to $104.6 million. This was driven by strong demand for its data centre services thanks to the accelerating shift to the cloud because of the pandemic. The good news is that the cloud computing boom still has a long way to run. I believe this means NEXTDC is perfectly positioned for growth over the 2020s. 

PolyNovo Ltd (ASX: PNV)

A final option for investors to consider buying is PolyNovo. It is a growing medical device company behind the NovoSorb Biodegradable Temporising Matrix (BTM) product. This is a wound dressing which is designed to treat full-thickness wounds and burns. Management estimates that it currently has a sizeable $1.5 billion addressable market. Though, it isn’t settling for this and is looking to expand its use into other markets. It has its eyes on the hernia and breast treatment markets, which would add a further $6 billion to its addressable market.

More reading

• Up 79% this year, is the NextDC (ASX:NXT) share price the next Afterpay (ASX:APT)?
• 4 unstoppable ASX shares to buy with $4,000
• What you need to know about Tyro’s share price roller coaster today
• Can Macquarie Telecom (ASX: MAQ) become the next NextDC?
• Where to invest $10,000 into ASX shares immediately

James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd and POLYNOVO FPO. The Motley Fool Australia has recommended Kogan.com ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Got $3,000? Buy these exciting ASX growth shares appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3kBcAmV

I love buying dirt-cheap ASX shares. Buying a good quality company at a cheap price greatly boosts your chances of enjoying market-beating returns in the years to come.

Most of the time, the market prices an ASX share at a reasonable price (that’s how markets work, after all). But sometimes, the market gets something wrong, and either gives us investors a chance to sell our shares at far above their true value, or else buy shares at far below their true value.

The 2 ASX shares I’ll name below are candidates (in my view) for such a mispricing right now. Here’s why.

2 dirt-cheap ASX shares

Telstra Corporation Ltd (ASX: TLS)

Telstra is our first dirt-cheap ASX share. It’s the largest telco company on the ASX and has been in the wars of late. Last month, Telstra delivered its results for the 2020 financial year. In this report, Telstra reaffirmed an annual dividend of 16 cents per share, but also implicitly warned that its earnings in FY21 will be unlikely to cover the dividend going forward. However, Telstra does have sufficient free cash flow to cover 16 cents per share, so I think investors are being a little pessimistic on Telstra today. But that also means that new investors can buy Telstra and receive a trailing and fully franked dividend yield of 5.65% on current prices. That’s not a bad deal in my view.

Cochlear Limited (ASX: COH)

Cochlear is our second dirt-cheap ASX share to consider today. This company makes hearing aids and other hearing assistive devices and treatments. Much like its fellow health care company CSL Limited (ASX: CSL) Cochlear shares have always commanded a healthy premium compared to other ASX shares. And this premium has been well-deserved. Cochlear is a world-class company that sets the industry standard when it comes to hearing aid products. But I like it today because I think the shares are trading at a rare discount. The Cochlear share price remains more than 24% below its 52-week high and still down around 7% year to date.

Sure, Cochlear has run into some issues during the pandemic, including delays in people getting Cochlear products installed. But in the long term, I don’t see any fundamental change to customers needing the services Cochlear provides. As such, I think today’s prices are a dirt-cheap deal for a long-term investor. You’ll also get a fully franked dividend worth a trailing 1.74% yield while you wait as well.

More reading

• How to reinvest an ASX dividend payment
• Is it time to buy Telstra and these high quality ASX 200 shares?
• Magellan (ASX:MFG) share price slides lower after investing in Barrenjoey
• Why the Telstra (ASX:TLS) share price looks cheap today
• ASX 200 Weekly Wrap: ASX 200 snaps 4 week losing streak… just

Motley Fool contributor Sebastian Bowen owns share of Telstra Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 2 dirt-cheap ASX shares I would buy today appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/35XRPhw